首页> 外文OA文献 >Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer

【2h】

Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer

机译：S-1单药治疗疗效的差异根据预处理患者的晚期非小细胞肺癌的组织学类型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yasushi Hisamatsu; Haruyasu Murakami; Hiroaki Akamatsu; Madoka Kimura; Keita Mori; Hisao Imai; Akira Ono; Takehito Shukuya; Tetsuhiko Taira; Hirotsugu Kenmotsu; Tateaki Naito; Masahiro Endo; Takashi Nakajima; Toshiaki Takahashi; Nobuyuki Yamamoto;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer [J] . HisamatsuY., MurakamiH., AkamatsuH., Thoracic cancer. . 2014,第2期

机译：根据组织学类型不同，S-1单一疗法在晚期非小细胞肺癌预治疗患者中的疗效差异
2. Differences in the efficacy of S‐1 monotherapy according to histological type in pretreated patients with advanced non‐small cell lung cancer [J] . Akira Ono, Haruyasu Murakami, Hiroaki Akamatsu, Thoracic cancer. . 2014,第2期

机译：预处理的晚期非小细胞肺癌患者中，根据组织学类型不同，S-1单一疗法的疗效差异
3. Efficacy differences of pemetrexed by histology in pretreated patients with stage IIIB/IV non-small cell lung cancer: review of results from an open-label randomized phase II study. [J] . Kubota K, Niho S, Enatsu S, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2009,第12期

机译：培美曲塞在IIIB / IV期非小细胞肺癌预处理患者中的组织学疗效差异：开放标签随机II期研究结果的回顾。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer [O] . Yasushi Hisamatsu, Haruyasu Murakami, Hiroaki Akamatsu, 2014

机译：根据组织学类型不同S-1单一疗法在晚期非小细胞肺癌患者中的疗效差异
7. Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer [O] . Seigo Minami, Shouichi Ihara, Tsunehiro Tanaka, 2020

机译：Sarcopenia和内脏肥胖不影响免疫检查点抑制剂单药治疗预处理患者的晚期非小细胞肺癌的疗效

Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer

著录项

引文网络

相似文献

相关主题

期刊订阅